Is it coercive or unfair for a state medical school to offer incremental tuition forgiveness for each year graduates practice primary care in the state?
Is it coercive or unfair for a state medical school to offer incremental tuition forgiveness for each year graduates practice primary care in the state?
Is it coercive or unfair for a state medical school to offer incremental tuition forgiveness for each year graduates practice primary care in the state?
Is it coercive or unfair for a state medical school to offer incremental tuition forgiveness for each year graduates practice primary care in the state?
Patients who use drugs intravenously may be at high risk for relapse, but their situation is no more futile than that of persons with diabetes and coronary artery disease who smoke and frequent all-you-can-eat buffets.
Dr Noah Boton joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Larnard: “When Should Patients at the End of Life Get Antimicrobials?”
Dr Jeannie P. Cimiotti joins Ethics Talk to discuss her article, coauthored with Drs Kimberly Adams Tufts, Lucia D. Wocial, and Elizabeth Peter: “How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections?”
Amy Fairchild, PhD, MPH, Ronald Bayer, PhD, and James Colgrove, PhD, MPH
A brief history of public opposition to disease surveillance in the U.S., despite the documented success of this tool in recognizing and managing threats to public health.